<DOC>
	<DOCNO>NCT02529800</DOCNO>
	<brief_summary>To investigate PK charateristics effect food PK healthy male volunteer receive HIP1402 capsule feed versus fast condition</brief_summary>
	<brief_title>Investigating Pharmacokinetic Characteristics HIP1402 Healthy Male Volunteers</brief_title>
	<detailed_description>A randomized , open-label , single dose , three-way crossover clinical trial investigate pharmacokinetics incorporate comparison fed/fasted pharmacokinetics HIP1402 healthy male volunteer</detailed_description>
	<criteria>1 . Healthy male volunteer , age 19~50 year 2 . Weight ≥55kg ≤90kg , The result Body Mass Index ( BMI ) less 18 kg/m2 , 27 kg/m2 3 . Subject ability comprehend study objective , content property study drug participate trial 4 . Subject ability willingness participate whole period trial 1 . Presence medical history concurrent disease may interfere treatment safety assessment completion clinical study , include clinically significant disorder kidney , liver , cardiovascular system , respiratory system , endocrine system , neuropsychiatric system . 2 . History relevant drug allergy clinically significant hypersensitivity reaction . 3 . Systolic Blood Pressure : low 100mmHg high 150mmHg , Diastolic Blood Pressure : low 60mmHg high 100mmHg 4 . Liver enzyme ( AST , ALT ) level exceeds maximum normal range one half time . 5 . Subjects take prescription drug within 14 day patient screen nonprescription medicine within 7 day affect result clinical trial ( acceptable accord investigator 's judgement ) 6 . Intake 210g alcohol per week ca n't abstain alcohol trial . 7 . Subjects smoke 10 cigarette per day ca n't quit smoke trial . 8 . Positive screening Hepatitis B surface antigen ( HBsAg ) , antiHepatitis C virus ( HCV ) antiHuman immunodeficiency virus ( HIV ) . 9 . Subjects judge ineligible investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>